An advisory panel to the US Food and Drug Administration on Tuesday gave its approval to an anti-obesity drug, in what could be the first new approved drug for losing weight in more than a decade. Contrave, a drug developed by the California-based Orexigen Therapies, was given the nod by a 13-7 vote by the [...]
Continue reading...Saturday, October 24, 2009
Nearly half of patients who completed 56 weeks of treatment with Orexigen Therapeutics Inc’s experimental obesity treatment, Contrave, lost at least 10 percent of their weight in a late-stage study and the drug also appeared to help cholesterol and blood sugar levels. The drug demonstrated an even greater improvement in non- weight loss measures in [...]
Continue reading...
Wednesday, December 8, 2010
0 Comments